Xcout Intel
Organon & Co.
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.
Subscribe to see Organon & Co.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Organon & Co. at a glance
Organon & Co. is a pharmaceuticals company headquartered in Jersey City, United States. It is publicly listed (OGN) with a market capitalisation of $3.6B. Xcout tracks 26 named people at Organon & Co., including Joseph T. Morrissey Jr. (Chief Executive Officer).
Organon & Co. leadership
- Joseph T. Morrissey Jr.Chief Executive Officer
- Joseph MorrisseyChief Executive Officer
- Matthew WalshExecutive Vice President & Chief Financial Officer
- Juan Camilo Arjona FerreiraExecutive Vice President, Head of Research & Development and Chief Medical Officer
- Rachel A. StahlerExecutive VP, Chief Information Officer and Chief Digital & Growth Officer
- Aaron FalcioneExecutive Vice President & Chief Human Resources Officer
20 more named people on record for Organon & Co., with roles, board committees and tenure — see the full roster →
Organon & Co. competitors
A few of Organon & Co.'s closest competitors — see the full list of competitors and alternatives →
Ferring Pharmaceuticals is a specialty biopharmaceutical company that develops and delivers treatments in reproductive medicine, maternal health, gastroenterology, urology, and uro-oncology. The company focuses on helping people build families, supporting maternal and infant health, and providing therapeutic solutions for various medical conditions worldwide.
Humanwell Healthcare (Group) Co.,Ltd. operates internationally, delivering a wide spectrum of healthcare solutions across regions including the Asia Pacific, North America, and Africa. The company's diverse product range features pharmaceuticals for pain management, such as anesthetics and analgesics, alongside a significant focus on women's health, providing items for reproductive planning, emergency contraception, and general wellness. They also produce central nervous system (CNS) medications addressing conditions like bronchitis, migraines, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, brain injuries, and peripheral vascular disorders. Furthermore, their offerings extend to traditional herbal remedies for common ailments such as colds and flu, rheumatoid arthritis, dermatological concerns, hepatitis, urinary tract infections, and memory impairment. Humanwell also supplies anti-infective agents, a variety of over-the-counter (OTC) drugs for digestive complaints, cold and flu relief, anti-inflammatory purposes, infections, and nutritional supplements. Complementing these, they offer specific treatments aimed at cardiovascular, gastrointestinal, and reproductive system diseases. Established in Wuhan, China, in 1993, the enterprise was initially known as Wuhan Humanwell Healthcare (Group) Co., Ltd. before adopting its current name, Humanwell Healthcare (Group) Co.,Ltd., in March 2013.
Jagsonpal Pharmaceuticals Limited is a Delhi-based public pharmaceutical company founded in 1978. Headquartered in Gurugram, Haryana, the company specializes in women's health and pharmaceutical products.
Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
Theramex is a British pharmaceutical company based in London which produces women's health products focusing on contraception, fertility, menopause and osteoporosis.
ObsEva is a biopharmaceutical company headquartered in Geneva, Switzerland, specifically in Plan-les-Ouates. The company focuses on developing and commercializing novel therapies for women's reproductive health. ObsEva has entered into global license agreements, such as with Organon, for the development of certain compounds.
Get Organon & Co.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Organon & Co. in Xcout Intel
- 26 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access